Hanbeitai (bevacizumab biosimilar) - Fosun Pharma, Eurofarma
Nerlynx (neratinib) - Puma
Hetronifly (serplulimab) - Fosun Pharma
Hercessi (trastuzumab-strf) - Fosun Pharma, Intas, Eurofarma
https://www.manilatimes.net/2026/03/20/tmt-newswire/pr-newswire/henlius-reports-2025-results-sustained-growth-in-both-revenue-and-profit-advancing-innovation-validation-and-global-operations/2304495
 
Mar 20, 2026
 
Prev Next